In other words, one drug might stop having an effect at the first half-life while another may still have an effect at the third half-life
Retatrutides Phase 2 data suggest that the addition of a third receptor target may extend the efficacy ceiling further still, though direct head-to-head trials would be needed to draw firm comparative conclusions
Glucose-lowering drugs, cognition, and dementia: the clinical evidence
Duration of treatment : Longer treatment periods may allow for better establishment of behavioral changes, though this doesn't prevent biological drivers of weight regain
It was terrifying, and I immediately stopped the drug. Ozempic is expensive, requires weekly shots, and, as you can see, comes with unpleasant and even scary side effects
Results may vary based on skin type and treatment frequency